Inmed Pharmaceuticals Inc Stock Earnings Per Share
| MWG0 Stock | 4.17 0.23 5.84% |
INMED PHARMACEUTICALS INC fundamentals help investors to digest information that contributes to INMED PHARMACEUTICALS's financial success or failures. It also enables traders to predict the movement of INMED Stock. The fundamental analysis module provides a way to measure INMED PHARMACEUTICALS's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to INMED PHARMACEUTICALS stock.
INMED |
INMED PHARMACEUTICALS INC Company Earnings Per Share Analysis
INMED PHARMACEUTICALS's Earnings per Share (EPS) denotes the portion of a company's earnings that is allocated to each share of common stock. To calculate Earnings per Share investors will need to take a company's net income, subtract any dividends for preferred stock, and divide it by the number of average outstanding shares. EPS is usually presented in two different ways: basic and diluted. Fully diluted Earnings per Share takes into account effects of warrants, options, and convertible securities and is generally viewed by analysts as a more accurate measure.
Earnings per Share is one of the most critical measures of the firm's current share price and is used by investors to determine the overall company profitability, especially when compared to the EPS of similar companies.
According to the company disclosure, INMED PHARMACEUTICALS INC has an Earnings Per Share of 0.0 times. This indicator is about the same for the average (which is currently at 0.0) sector and about the same as Earnings Per Share (which currently averages 0.0) industry. This indicator is about the same for all Germany stocks average (which is currently at 0.0).
Did you try this?
Run Portfolio Comparator Now
Portfolio ComparatorCompare the composition, asset allocations and performance of any two portfolios in your account |
| All Next | Launch Module |
About INMED PHARMACEUTICALS Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze INMED PHARMACEUTICALS INC's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of INMED PHARMACEUTICALS using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of INMED PHARMACEUTICALS INC based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Other Information on Investing in INMED Stock
INMED PHARMACEUTICALS financial ratios help investors to determine whether INMED Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in INMED with respect to the benefits of owning INMED PHARMACEUTICALS security.